Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). (Q38206066)

31 August 2017

Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). (English)

1 reference

31 August 2017

0 references

Nelson B Watts

1

1 reference

PubMed ID

24751880

31 August 2017

GLOW investigators

series ordinal

2

1 reference

31 August 2017

22 April 2014

1 reference

Nature Reviews Endocrinology

31 August 2017

1 reference

31 August 2017

10

1 reference

31 August 2017

7

1 reference

31 August 2017

412-422

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2014.55

31 August 2017

0 references

cites work

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Undertreatment with anti-osteoporotic drugs after hospitalization for fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Using the SF-36 and Euroqol on an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Epidemiology of lifetime fracture prevalence in England: a population study of adults aged 55 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Trends in fracture incidence: a population-based study over 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Declining incidence of osteoporotic hip fracture in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Updated fracture incidence rates for the US version of FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Long-term risk of osteoporotic fracture in Malmö.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Incidence and seasonal variation in hip fracture incidence among elderly women in Norway. The HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Epidemiology of hip fractures in Oslo, Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Incidence of hip fractures in Malmö, Sweden, 1992-1995. A trend-break

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Fecundability of female twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Variation in the incidence of distal radius fractures in the U.S. elderly as related to slippery weather conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Modeling seasonal variation of hip fracture in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Low-energy distal radius fractures in middle-aged and elderly women-seasonal variations, prevalence of osteoporosis, and associates with fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Characteristics and circumstances of falls in hip fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Epidemiology and outcome of fracture of the hip in women aged 65 years and under: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

The role of falls in fracture prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Obesity is not protective against fracture in postmenopausal women: GLOW

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Predicting fractures in an international cohort using risk factor algorithms without BMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Does a Fracture at One Site Predict Later Fractures at Other Sites? A British Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Frailty in older adults: evidence for a phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Obesity and risk of hip fracture in adults: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Obesity and fracture in men and women: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Risk stratification and therapeutic decision making in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Evaluating the yield of medical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Women with cardiovascular disease have increased risk of osteoporotic fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Severity of osteoporosis: what is the impact of co-morbidities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Risk of fractures in patients with multiple sclerosis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Effect of seasonality and weather on fracture risk in individuals 65 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Follow-up treatment for osteoporosis after fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Major osteoporotic to hip fracture ratios in canadian men and women with Swedish comparisons: a population-based analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Epidemiology of hip fractures in Okinawa, Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Evaluating the yield of medical tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.55

Epidemiology of falls and osteoporotic fractures: a systematic review

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751880

12 December 2020

inferred from PubMed ID database lookup

Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States, 1984-1987

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751880

12 December 2020

inferred from PubMed ID database lookup

Inclement weather and the risk of hip fracture

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751880

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRENDO.2014.55

1 reference

release_qnmfifb5nbc45fehbmvdvlgyva

31 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qnmfifb5nbc45fehbmvdvlgyva

24 November 2022

mapped directly with Wikidata item

PubMed ID

24751880

1 reference

PubMed ID

24751880